LEADER 02946oam 2200601 a 450 001 9910956900203321 005 20240410170733.0 010 $a1-61324-472-X 035 $a(CKB)2670000000095650 035 $a(EBL)3019682 035 $a(SSID)ssj0000522128 035 $a(PQKBManifestationID)12230601 035 $a(PQKBTitleCode)TC0000522128 035 $a(PQKBWorkID)10527764 035 $a(PQKB)10950499 035 $a(MiAaPQ)EBC3019682 035 $a(Au-PeEL)EBL3019682 035 $a(CaPaEBR)ebr10671247 035 $a(OCoLC)738478405 035 $a(BIP)27528557 035 $a(EXLCZ)992670000000095650 100 $a20090820h20102010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDrug monitoring by HPLC $erecent developments /$fVictoria Samanidou and Eftichia Karageorgou 205 $a1st ed. 210 1$aNew York :$cNova Science Publishers,$d2010. 210 4$dİ2010 215 $a1 online resource (viii, 127 pages) $cillustrations 225 1 $aPharmacology : research, safety testing and regulation series 300 $aDescription based upon print version of record. 311 0 $a1-60876-183-5 320 $aIncludes bibliographical references and index. 327 $aBrief introduction to HPLC -- Sample preparation -- Anti-cancer drugs -- Bronchodilators -- Cardiovascular drugs -- Antipsychotics -- Antibiotics -- Antiepileptic drugs -- Antidepressants -- Immunosuppressants. 330 $aRecently HPLC-MS/MS has gained increasing popularity in clinical laboratories due to the advantages of the technology over other methods, while the capital cost for instruments has been decreased. HPLC-MS/MS provides high specificity and sensitivity for the simultaneous measurement of several drugs and/or their major metabolites in one single analytical run. In this new book chromatographic methods published in the last decade are reviewed regarding their applicability to drug monitoring. HPLC methods for anti-cancer drugs, bronchodilators, cardiovascular drugs, antipsychotics, antibiotics, antiepileptic drugs, antidepressants, and immunosuppressants have been presented comprehensively regarding sample preparation and chromatographic separation. Supportive information has been included on HPLC analysis and sample preparation. 410 0$aPharmacology-research, safety testing, and regulation series. 606 $aHigh performance liquid chromatography 606 $aDrugs$xAnalysis 615 0$aHigh performance liquid chromatography. 615 0$aDrugs$xAnalysis. 676 $a615/.1901 700 $aSamanidou$b Victoria$01174648 701 $aKarageorgou$b Eftichia$01868758 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910956900203321 996 $aDrug monitoring by HPLC$94476761 997 $aUNINA